Advertisement

An exclusive letter of intent for licensing of UC San Francisco's stem cell injection technology prompts major changes at China's Sitoa Global.

UCSF and Sitoa Global sign global deal for brain stem cell injection technology

China-based Sitoa Global is making some big moves after landing an exclusive licensing contract with UC San Francisco, according to a company announcement.

Sitoa signed an exclusive letter of intent for UCSF's "medical stereotactic device," designed to streamline the therapeutic delivery of stem cells into the brain.

Advertisement
Advertisement